← Back to Search

Exercise Program for Breast Cancer

Honolulu, HI
N/A
Waitlist Available
Led By Jami Fukui, MD
Research Sponsored by University of Hawaii
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participant must be able to lie flat on their back for up to 10 minutes
Participant must be able to stand without aid for at least 2 minutes
Must not have
Participant with breast cancer recurrence
Metastatic breast cancer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing if an exercise program can change the body composition of breast cancer patients, and if they can keep up the physical activity after the program.

See full description
Who is the study for?
This trial is for individuals newly diagnosed with breast cancer (within the past 2 years, stages I-III) who can be undergoing various treatments. Participants must be able to perform physical activities like lying flat and standing without aid, and commit to a 12-week exercise program including assessments.Check my eligibility
What is being tested?
The study tests the impact of a 12-week exercise regimen on body composition in breast cancer patients. It also aims to identify factors that encourage ongoing physical activity post-intervention.See study design
What are the potential side effects?
While not explicitly listed, potential side effects from participating in an exercise program may include muscle soreness, fatigue, and risk of injury. Specific side effects will depend on individual health status.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can lie flat on my back for up to 10 minutes.
 show original
Select...
I can stand on my own for at least 2 minutes.
 show original

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My breast cancer has come back.
 show original
Select...
My breast cancer has spread to other parts of my body.
 show original

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Automatic 3D optical (3DO) scan measurement: girth measurement
Automatic 3D optical (3DO) scan measurement: length measurement
Automatic 3D optical (3DO) scan measurement: volume measurement
+8 more
Secondary study objectives
BFI-Brief Fatigue Innovatory questionnaire
BIBCQ-Body Image After Breast Cancer questionnaire
Biomarkers
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Group 2 - Declines Exercise ProgramActive Control1 Intervention
Same biometric and biomarker assessment at as Group 1 (at baseline, after 12 weeks and annually) however they will not participate in the exercise sessions
Group II: Group 1 - Agree to Exercise ProgramActive Control1 Intervention
12-week exercise program

Find a Location

Closest Location:University of Hawaii Cancer Center· Honolulu, HI· 3722 miles

Who is running the clinical trial?

Rehabilitation Hospital of the PacificUNKNOWN
University of HawaiiLead Sponsor
121 Previous Clinical Trials
55,026 Total Patients Enrolled
2 Trials studying Breast Cancer
673 Patients Enrolled for Breast Cancer
Jami Fukui, MDPrincipal InvestigatorUniversity of Hawaii Cancer Research Center

Media Library

Exercise Clinical Trial Eligibility Overview. Trial Name: NCT04013568 — N/A
Breast Cancer Research Study Groups: Group 2 - Declines Exercise Program, Group 1 - Agree to Exercise Program
Breast Cancer Clinical Trial 2023: Exercise Highlights & Side Effects. Trial Name: NCT04013568 — N/A
Exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT04013568 — N/A
~33 spots leftby Sep 2026